Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1993-03-17
1997-09-02
Fleisher, Mindy
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 931, 4353201, 514 44, A61K 4800, C12N 1586, C12N 1523, C12N 1526
Patent
active
056628960
ABSTRACT:
The present invention provides methods for inhibiting the growth of selected tumors utilizing recombinant viral vectors. Briefly, within one aspect of the present invention, a method for inhibiting the growth of a selected tumor is provided comprising the step of directly administering to a warm-blooded animal a vector construct which directs the expression of at least one anti-tumor agent, such that the growth of said tumor is inhibited. Representative examples of anti-tumor agents include immune activators and tumor proliferation inhibitors.
REFERENCES:
patent: 5223408 (1993-06-01), Goeddel et al.
Nishihara K., "A Novel Experimental Approach to Immunotherapy against Malignant Brain Tumor with the Mouse IFN-.gamma. Gene Transfer," Arch. Jpn. Chir. 58(1):18-42 (1989). (English abstract).
Culver et al., "In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors," Science 256: 1550-1552, 1992.
Panis, Y. et al., "Traitement de turmeurs hepatiques experimentales par transfert de gene suicide in vivo chez le rat," Comptes Rendus de L'Academie des Sciences: Serie III 315: 541-544, 1992.
Takamiya et al., "Gene Therapy of Malignant Brain Tumors: A Rat Glioma Line Bearing the Herpes Simplex Virus Type 1-Thymidine Kinase Gene and Wild Type Retrovirus Kills Other Tumor Cells," Journal of Neuroscience Research 33(3):493-503, 1992.
Moolten and Wells, "Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transferred by Retroviral Vectors," Journal of the National Cancer Institute 82(4): 297-300, 1990.
Moolten, F., "Tumor Chemosensitivity Conferred by Inserted Herpes Thymidine Kinase Genes: Paradigm for a Prospective Cancer Control Strategy," Cancer Research 46(10): 5276-5281, 1986.
Ram et al., "In Situ Retroviral-mediated Gene Transfer for the Treatment of Brain Tumors in Rats," Cancer Research 53(1): 83-88, 1993.
Georges et al., "Prevention of Orthotopic Human Lung Cancer Growth by Intratracheal Instillation of a Retroviral Antisense K-ras Construct," Cancer Research 53(8): 1743-1746, 1993.
Nabel et al., "Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans," Proc. Natl. Acad. Sci. USA 90(23): 11307-11311, 1993.
Jaffe et al., "High Efficiency Gene Transfer into Primary Human Tumor Explants without Cell Selection," Cancer Research 53: 2221-2226, 1993.
Colombo and Forni, "Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?, " Immunology Today 15(2): 48-51, 1994.
Hock et al., "Interleukin 7 Induces CD4.sup.+ Cell-dependent Tumor Rejection," Journal of Experimental Medicine 174: 1291-1298, 1991.
Aoki et al., "Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo," Proc. Natl. Acad. Sci. USA 89: 3850-3854, 1992.
Stoppacciaro et al., "Regression of an Established Tumor Genetically Modified to Release Granulocyte Colony-stimulating Factor Requires Granulocyte-T Cell Cooperation and T Cell-produced Interferon .gamma.," Journal of Experimental Medicine 178: 151-161, 1993.
Dranoff et al., "Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity," Proc. Natl. Acad. Sci. USA 90: 3539-3543, 1993.
Colombo et al. "Granulocyte Colony-stimulating Factor Gene Transfer Supresses Tumorigenicity of a Murine Adenocarcinoma In Vivo," Journal of Experimental Medicine 173: 889-897, 1991.
Nabel et al., "Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors," Human Gene Therapy 3: 339-410, 1992.
Caruso et al., "Regression of established macroscopic liver metastases after in situ transduction of a suicide gene," Proc. Natl. Acad. Sci. 90: 7024-7028, 1993.
Wallach et al., "Preferential effect of .gamma. interferon on the synthesis of HLA antigens and their mRNAs in human cells," Nature 299: 833-836, 1982.
Carrel et al., "Recombinant interferon-.gamma. can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens," European Journal of Immunology 15: 118-123, 1985.
Stevenson, F., "Tumor vaccines," FASEB Journal 5: 2250-2257, 1991.
Tanaka et al., "Rejection of B16 Melanoma Induced by Expression of a Transfected Major Histocompatibility Complex Class I Gene," Mol. Cell. Biol. 8(4): 1857-1861, 1988.
Watanabe et al., "Exogenous expression of mouse interferon .gamma. cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity," Proc. Natl. Acad. Sci. 86: 9456-9460, 1989.
Nishihara et al., "Augmentation of Tumor Targeting in a Line of Glioma-specific Mouse Cytotoxic T-Lymphocytes by Retroviral Expression of Mouse .gamma.-Interferon Complementary DNA," Cancer Research 48: 4730-4735, 1988.
Darrow et al., "The Role of HLA Class I Antigens In Recognition of Melanoma Cells By Tumor-Specific Cytotoxic T Lymphocytes: Evidence for Shared Tumor Antigens.," Journal of Immunology 142(9): 3329-3335, 1989.
Vose, B., "Quantitation Of Proliferative And Cytotoxic Precursor Cells Directed Against Human Tumours: Limiting Dilution Analysis In Peripheral Blood And At The Tumour Site," International Journal of Cancer 30: 135-142, 1982.
Ioannides et al., "Cytotoxic T Cell Clones Isolated From Ovarian Tumor-Infiltrating Lymphocytes Recognize Multiple Antigenic Epitopes On Autologous Tumor Cells," Journal of Immunology 146: 1700-1707, 1991.
Eglitis et al., "Expression Of Lymphokine Genes Using Retroviral Vectors," Journal of Cellular Biochemistry (Supp. 14A): 367, 1990.
Golumbek et al., "Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4," Science 254: 713-716, 1991.
Esumi et al., "Reduced Tumorigenicity of Murine Tumor Cells Secreting .gamma.-Interferon Is Due to Nonspecific Host Responses and Is Unrelated to Class I Major Histocompatibility Complex Expression," Cancer Research 51: 1185-1189, 1991.
Fearon et al., "Interleukin-2 Production by Tumor Cells Bypasses T Helper Function in the Generation of an Antitumor Response," Cell 60: 397-403, 1990.
Tepper et al., "Murine Interleukin-4 Displays Potent Anti-Tumor Activity in Vivo," Cell 57: 503-512, 1989.
Fellous et al., "Enhanced expression of HLA antigens and .beta..sub.2 -microglobulin on interferon-treated human lymphoid cells," European Journal Immunology 9: 446-449, 1979.
Fellous et al., "Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells," Proc. Natl. Acad. Sci. 79: 3082-3086, 1982.
Alter et al., "Sporadic Non-A, Non-B Hepatitis: Frequency and Epidemiology in an Urban U.S. Population," Journal of Infect. Dis. 145: 886-893, 1982.
Natali et al., "Heterogeneity in the Expression of HLA and Tumor-associated Antigens by Surgically Removed and Cultured Breast Carcinoma Cells," Cancer Research 43: 660-668, 1983.
Collins et al., "Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts," Proc. Natl. Acad. Sci. 81:4917-4921, 1984.
Herlyn et al., "Efficient Selection of Human Tumor Growth-Inhibiting Monoclonal Antibodies," Journal of Immunological Methods 73: 157-167, 1984.
Giacomini et al., "A third polypeptide associated with heavy and light chain subunits of class I HLC antigens in immune interferon-treated human melanoma cells," European Journal of Immunology 15: 946-951, 1985.
Yamasaki et al., "Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone," Journal of Neurosurgery 63: 763-770, 1985.
Gerber and Thung, "Biology of Disease: Molecular and Cellular Pathology of Hepatitis B," Lab. Invest. 52: 572-590, 1985.
Norton and Coffin, "Bacterial .beta.-Galactosidase as a Marker of Rous Sarcoma Virus Gene Expression and Replication," Molecular and Cellular Biology 5: 281-290, 1985.
Giacomini et al., "Recombinant Human
Barber Jack R.
Jolly Douglas J.
Respess James G.
Blackburn Robert P.
Chiron Viagene, Inc.
Fleisher Mindy
Kruse Norman J.
Railey II Johnny F.
LandOfFree
Compositions and methods for cancer immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for cancer immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for cancer immunotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-305997